Bayer's CEO: We Develop Drugs For Rich Westerners, Not Poor Indians

from the refreshingly-honest dept

We've covered the continuing efforts of emerging economies to provide key medicines for their populations at affordable prices. To do that, they often invoke their right to use compulsory licensing to bring down costs. For understandable reasons, the big pharma companies aren't happy with that approach, but usually dress it up as a concern about the supposed threat to "innovation" that it represents -- their claim being high prices are needed to fund expensive research. But as Techdirt has noted, pharma's estimates of expenditure here tend to be hugely inflated, which rather undercuts that argument.

One of the companies that has been affected by compulsory licensing moves in India is Bayer. Here's what its CEO said on the subject according to a report in Bloomberg Businessweek:

Bayer Chief Executive Officer Marijn Dekkers called the compulsory license "essentially theft."

"We did not develop this medicine for Indians," Dekkers said Dec. 3. "We developed it for western patients who can afford it."
That's a refreshingly honest admission that rather than wanting to save lives around the world, what Bayer is interested in is maximizing its profits by selling expensive drugs to "western patients who can afford it," and that those who can't pay can just, well, drop dead -- which, of course, is precisely what many of them will do without Bayer's drugs.

Some might say that's a perfectly reasonable position -- after all, Bayer and the other pharmaceutical companies are for-profit concerns. But they weren't always so dismissive of humanitarian concerns. Here's what George Merck, who became president of his father's eponymous chemical manufacturing company in 1929, said on the subject, as quoted on the Today in Science History site:

We try never to forget that medicine is for the people. It is not for the profits. The profits follow, and if we have remembered that, they have never failed to appear. The better we have remembered it, the larger they have been.
Bayer's CEO obviously disagrees.

Follow me @glynmoody on Twitter or identi.ca, and +glynmoody on Google+

Filed Under: drugs, india, marijn dekkers, pharmaceuticals, poor, rich
Companies: bayer, merck


Reader Comments

The First Word

Subscribe: RSS

View by: Time | Thread


  1. identicon
    James watts, 21 Feb 2017 @ 11:04am

    The problem is that almost every single private company in the world use public resources to make their products, most of it in the form of public funded research, infrastructure, social framework, etc. and they are supposed to give back in the form of taxes but they do not, they want the cake and to eat the whole cake themselves.

    Epipen is one clear case, the device itself was made in its entirety by the USA government
    http://usuncut.com/class-war/epipen-taxpayer-money/

    But Mylan got a monopoly in the US, thanks to the senator Joe Manchin and his daughter Heather Bresch corruption
    http://freebeacon.com/issues/government-funds-mylan-spiked-sen-manchins-daughter-became-ce o


    http://abcnews.go.com/WNT/YourMoney/story?id=129651
    http://www.citizen.org/publications/publicationr edirect.cfm?ID=7065

    The irony of this form of capitalism is that it relies on socialism to be profitable.

Add Your Comment

Have a Techdirt Account? Sign in now. Want one? Register here



Subscribe to the Techdirt Daily newsletter




Comment Options:

  • Use markdown. Use plain text.
  • Remember name/email/url (set a cookie)

Follow Techdirt
Special Affiliate Offer

Advertisement
Report this ad  |  Hide Techdirt ads
Essential Reading
Techdirt Deals
Report this ad  |  Hide Techdirt ads
Techdirt Insider Chat
Advertisement
Report this ad  |  Hide Techdirt ads
Recent Stories
Advertisement
Report this ad  |  Hide Techdirt ads

Close

Email This

This feature is only available to registered users. Register or sign in to use it.